Keeping you up to date on recent developments in oncology, including: Cellular ‘backpack’ boosts activity of macrophages against cancer; Hardware + software = slide-free histology; Researchers wary of social media for clinical trial recruitment; Peptides team up with nanowires to detect cancer exosomes.

Keeping you up to date on recent developments in oncology, including: Microscopic robots inch closer to clinical practicability; One thing often leads to another for cancer patients; PARP inhibitors under more scrutiny; New liposome may suppress false positives in FDG-PET.

Keeping you up to date on recent developments in oncology, including: Multicancer screening paradigm bolstered in new study; Potentiating PARP inhibitors; New non-viral vector siRNA approach described; NICE nods to combo therapy for HCC.

Keeping you up to date on recent developments in oncology, including: Study clarifies distinct genomic features of early-onset appendiceal cancer; MET no better than EMT for cancer metastases; MRI may offer risk-stratification for glioblastoma; Study supports short telomeres as protective against cancer.

Keeping you up to date on recent developments in oncology, including: New theranostic nanoparticle design combines DNA wireframe and Sgc8c aptamer; Bolting TLR agonist to antibody converts cold tumors; Rule-based screening for degraders; How stress disrupts tumor cell sleep; Combo treatment shows efficacy in treatment of ALL.

Keeping you up to date on recent developments in oncology, including: New assay may aid in the use of proteases as diagnostic for a range of cancers; New vulnerability in ‘KL’ KRAS subtype; Ferropoptosis gains new credibility as cancer treatment.

Keeping you up to date on recent developments in oncology, including: Nanoparticles may blunt TRIM37’s impact on metastasis in triple-negative breast cancer; Glycolysis inhibition via collateral lethality; Making exceptional responders unexceptional; Protons may spare cancer patients a hit to the heart.

Keeping you up to date on recent developments in oncology, including: Prolonged androgen-deprivation therapy confirmed as hit on CV health; Nanoparticle fights pancreatic cancer’s chemo resistance; Linking two liver cancer culprits; Reversal of pumping direction is reversal of fortune for tumor cells; Active surveillance backed for Black men with prostate cancer.

Keeping you up to date on recent developments in oncology, including: Blood test does well in distinguishing between malignant, benign growths; PARP inhibition can assist tumor cells; CDK 4/6 inhibitors affect transcriptional landscape.

Keeping you up to date on recent developments in oncology, including: Microfluidic provides model for testing therapies on pancreatic ductal adenocarcinoma; Cutting off AML’s metabolic escape route; NGF: PDAC’s VEGF?; Revving up cisplatin by targeting Rev7.